Pharma-Bio Serv (PBSV) Assets Average (2011 - 2026)

Pharma-Bio Serv (PBSV) has reported Assets Average for 14 consecutive years, with $12.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 16.45% year-over-year to $12.5 million; the trailing twelve-month figure through Apr 2026 stood at $12.5 million (down 16.45% YoY), and the FY2025 full-year result was $15.0 million, down 17.27% from the prior year.
• Assets Average fell to $12.5 million in Q2 2026 per PBSV's latest filing, from $13.6 million in the prior quarter.
• Across five years, Assets Average topped out at $23.0 million in Q1 2022 and bottomed at $12.5 million in Q2 2026.
• Historically, Assets Average has averaged $18.0 million across 5 years, with a median of $18.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Assets Average retreated 28.33% in 2022, then climbed 0.67% in 2023.
• Over 5 years, Assets Average stood at $20.5 million in 2022, then slipped by 1.91% to $20.1 million in 2023, then dropped by 18.88% to $16.3 million in 2024, then retreated by 16.47% to $13.6 million in 2025, then slipped by 8.04% to $12.5 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $12.5 million, $13.6 million, and $13.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.